Hugh Bostock Selected Research

Hugh Bostock Research Topics

Disease

8	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2024 - 04/2006
3	Neuralgia (Stump Neuralgia) 01/2022 - 02/2011
3	Muscular Diseases (Myopathy) 01/2022 - 08/2014
3	Critical Illness (Critically Ill) 01/2022 - 08/2014
2	Polyneuropathies (Polyneuropathy) 01/2022 - 12/2009
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022 - 01/2012
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 02/2016
2	Channelopathies 01/2020 - 10/2012
2	Muscle Weakness 01/2018 - 08/2014
2	Peritonitis 01/2018 - 08/2014
2	Hyperalgesia 01/2018 - 06/2004
2	Sepsis (Septicemia) 01/2018 - 08/2014
2	Myotonia 01/2018 - 01/2016
2	Type 1 Episodic Ataxia 10/2013 - 12/2010
2	Guillain-Barre Syndrome 12/2003 - 08/2002
1	Motor Neuron Disease (Primary Lateral Sclerosis) 03/2024
1	Cognitive Dysfunction 04/2022
1	COVID-19 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Hyperkalemic Periodic Paralysis 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2017
1	Type 2 Episodic Ataxia 02/2016
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2016
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 11/2014
1	Isaacs Syndrome (Neuromyotonia) 11/2014
1	Myotonia Congenita (Thomsen Disease) 06/2014
1	Congenital Abnormalities (Deformity) 06/2014
1	Ataxia (Dyssynergia) 10/2013
1	Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions) 10/2012
1	Orthostatic Hypotension (Postural Hypotension) 12/2011
1	Acute Intermittent Porphyria (Porphyria, Acute) 09/2008
1	Inflammation (Inflammations) 12/2006
1	Fasciculation (Fasciculations) 07/2006
1	Poisoning 03/2005

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2021
4	Ion Channels (Ion Channel)IBA 01/2022 - 02/2016
4	Sodium Channels (Sodium Channel)IBA 01/2018 - 08/2014
4	Potassium Channels (Potassium Channel)IBA 10/2012 - 04/2006
2	Chloride Channels (Chloride Channel)IBA 01/2016 - 06/2014
2	Amantadine (Aman)FDA LinkGeneric 12/2003 - 08/2002
1	PotassiumIBA 12/2021
1	SodiumIBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	Calcium Channels (Calcium Channel)IBA 02/2016
1	voltage-dependent calcium channel (P-Q type)IBA 02/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2016
1	CalciumIBA 02/2016
1	Proteins (Proteins, Gene)FDA Link 11/2014
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 11/2014
1	AutoantibodiesIBA 11/2014
1	AntibodiesIBA 11/2014
1	4-O-carboxymethylascochlorinIBA 08/2014
1	Kv1.1 Potassium ChannelIBA 10/2013
1	Potassium Chloride FDA LinkGeneric 10/2012
1	Indicators and Reagents (Reagents)IBA 12/2011
1	Menthol FDA Link 12/2009
1	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 09/2008
1	Serotonin (5 Hydroxytryptamine)IBA 12/2006
1	Tetrodotoxin (Tetradotoxin)IBA 03/2005
1	Capsaicin (Zostrix)FDA Link 06/2004

Therapy/Procedure

3	Transcranial Magnetic Stimulation 12/2023 - 01/2021
3	Critical Care (Surgical Intensive Care) 01/2022 - 08/2014
2	Resuscitation 01/2018 - 08/2014
2	Nerve Crush 01/2012 - 02/2011
2	Sutures (Suture) 01/2012 - 02/2011
1	Drug Therapy (Chemotherapy) 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Renal Dialysis (Hemodialysis) 12/2021
1	Intradermal Injections 06/2004